Furthermore, they have shown that Withaferin A can prevent the increased production of IL-10 by MDSCs upon cross-talking with MΦ, therefore inhibiting pro-tumour immune responses, namely type 2 immune responses [149]. Here, IL10 is linked to neoplasm.